美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Hemab Therapeutics Holdings, Inc.

42.57

+1.603.91%

成交量：9.30萬

成交額：397.53萬

市值：19.88億

市盈率：-23.89

高：43.47

開：41.23

低：40.99

收：40.97

52周最高：55.42

52周最低：23.00

股本：4,670.54萬

流通股本：1,675.00萬

量比：1.48

換手率：0.56%

股息：- -

股息率：- -

每股收益(TTM):-1.7820

每股收益(LYR):-67.5613

淨資產收益率：-46.99%

總資產收益率：-30.11%

市淨率：4.38

市盈率(LYR):-0.63

資料載入中...

總覽公司新聞資訊公告

Hemab Therapeutics宣佈Hmb-003治療重度月經出血的1期臨床試驗首例受試者完成給藥

美國研究綜述-卡迪納爾健康、盧門圖姆控股、公共倉儲

H.C. Wainwright 首次覆蓋 Hemab Therapeutics，給予「買入」評級及40美元目標價

美國研究綜述-阿波羅、菲利普斯66、瓦萊羅能源

諾和諾德基金會參投的生物科技公司Hemab(COAG.US)擬赴美IPO，最高募資2.12億美元

Hemab Therapeutics Holdings Inc提交SEC文件：預計IPO股價區間為16-18美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/COAG/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"COAG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COAG\",,,,,undefined,":{"symbol":"COAG","market":"US","secType":"STK","nameCN":"Hemab Therapeutics Holdings, Inc.","latestPrice":42.57,"timestamp":1789655190094,"preClose":40.97,"halted":0,"volume":92971,"delay":0,"changeRate":0.03905296558457411,"floatShares":16750000,"shares":46705400,"eps":-1.782,"marketStatus":"交易中","change":1.6,"latestTime":"09-17 10:26:31 EDT","open":41.23,"high":43.465,"low":40.985,"amount":3975275.587272,"amplitude":0.060532,"askPrice":43.13,"askSize":300,"bidPrice":42.76,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-1.782,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"listingDate":1777608000000,"exchange":"NASDAQ","adjPreClose":40.97,"postHourTrading":{"tag":"盘后","latestPrice":40.97,"preClose":40.97,"latestTime":"17:26 EDT","volume":2773,"amount":113602.74,"timestamp":1789593972612,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.475735},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COAG\",,,,,undefined,":{"symbol":"COAG","floatShares":16750000,"roa":"-30.11%","roe":"-46.99%","lyrEps":-67.56131,"volumeRatio":1.475735,"shares":46705400,"dividePrice":0,"high":43.465,"amplitude":0.060532,"preClose":40.97,"low":40.985,"week52Low":23.0001,"pbRate":"4.38","week52High":55.42,"institutionHeld":0,"latestPrice":42.57,"committee":-0.935484,"eps":-1.782,"divideRate":0,"volume":92971,"delay":0,"ttmEps":-1.782,"open":41.23,"prevYearClose":18,"prevWeekClose":39.4,"prevMonthClose":45.73,"prevQuarterClose":36.73,"fiveDayClose":39.88,"twentyDayClose":51.66,"sixtyDayClose":29.15},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COAG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"COAG","fiscalQuarterEnding":"2026/06","expectedEps":-0.63,"name":null,"time":"盤前","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-0.8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COAG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"COAG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1781755200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/COAG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"COAG","date":"2026-09-16","current":-22.991021,"percent":0.505376,"low":-34.170536,"twenty":-29.449816,"median":-22.611055,"eighty":-18.175006,"high":-11.042152,"avg":-23.646503,"sd":5.401541,"marketCap":1873623012},"quantilePoints":[{"date":"2026-05-01","current":-11.042152,"twenty":-11.042152,"median":-11.042152,"eighty":-11.042152,"marketCap":705737088},{"date":"2026-05-08","current":-17.79803,"twenty":-17.79803,"median":-17.407359,"eighty":-17.286354,"marketCap":1137525503},{"date":"2026-05-15","current":-19.616555,"twenty":-19.616555,"median":-17.521449,"eighty":-17.286354,"marketCap":1253752856},{"date":"2026-05-22","current":-18.185245,"twenty":-19.409118,"median":-17.853347,"eighty":-17.293269,"marketCap":1162273533},{"date":"2026-05-29","current":-19.360717,"twenty":-19.450605,"median":-18.046954,"eighty":-17.354117,"marketCap":1237401480},{"date":"2026-06-05","current":-17.56985,"twenty":-19.450605,"median":-18.185245,"eighty":-17.491025,"marketCap":1122941843},{"date":"2026-06-12","current":-18.627775,"twenty":-19.370397,"median":-18.1403,"eighty":-17.515917,"marketCap":1190556995},{"date":"2026-06-18","current":-18.288963,"twenty":-19.294337,"median":-18.002009,"eighty":-17.444006,"marketCap":1168902469},{"date":"2026-06-26","current":-18.159648,"twenty":-19.492093,"median":-18.185245,"eighty":-17.510385,"marketCap":1294673965},{"date":"2026-07-02","current":-21.291074,"twenty":-19.764526,"median":-18.302792,"eighty":-17.540809,"marketCap":1517925825},{"date":"2026-07-10","current":-24.370091,"twenty":-20.501011,"median":-18.714206,"eighty":-17.578148,"marketCap":1737441252},{"date":"2026-07-17","current":-29.172047,"twenty":-21.688778,"median":-18.837687,"eighty":-17.609955,"marketCap":2079791907},{"date":"2026-07-24","current":-30.02369,"twenty":-24.062189,"median":-19.305401,"eighty":-17.650059,"marketCap":2140508940},{"date":"2026-07-31","current":-31.09807,"twenty":-25.689482,"median":-19.512836,"eighty":-17.666654,"marketCap":2217105812},{"date":"2026-08-07","current":-34.170536,"twenty":-29.287346,"median":-19.706444,"eighty":-17.692929,"marketCap":2436154185},{"date":"2026-08-14","current":-30.277152,"twenty":-30.021629,"median":-19.996854,"eighty":-17.818774,"marketCap":2520118712},{"date":"2026-08-21","current":-27.050208,"twenty":-30.064832,"median":-20.629413,"eighty":-17.903131,"marketCap":2251524039},{"date":"2026-08-28","current":-27.774166,"twenty":-30.021629,"median":-21.296443,"eighty":-17.946001,"marketCap":2311782670},{"date":"2026-09-04","current":-24.900782,"twenty":-29.906697,"median":-22.201677,"eighty":-18.108214,"marketCap":2072616631},{"date":"2026-09-11","current":-22.38096,"twenty":-29.479949,"median":-23.509442,"eighty":-18.159648,"marketCap":1862879225},{"date":"2026-09-16","current":-22.510038,"twenty":-29.449816,"median":-22.611055,"eighty":-18.175006,"marketCap":1873623012}],"updateTime":1789638773710},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COAG\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1199925896","title":"Hemab Therapeutics宣佈Hmb-003治療重度月經出血的1期臨床試驗首例受試者完成給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=1199925896","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199925896?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 20:01","pubTimestamp":1789646470,"startTime":"0","endTime":"0","summary":"Hemab Therapeutics今日宣布，其用于管理重度月经出血的在研疗法Hmb-003，已在1期临床试验中完成首例受试者给药。这一里程碑标志着该候选药物正式进入人体临床评估阶段。\nHmb-003是一种新型 investigational 疗法，旨在为饱受重度月经出血困扰的患者提供更优的治疗选择。此次1期试验的主要目标在于评估药物的安全性、耐受性及药代动力学特征，为进一步的临床开发奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COAG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658927621","title":"美國研究綜述-卡迪納爾健康、盧門圖姆控股、公共倉儲","url":"https://stock-news.laohu8.com/highlight/detail?id=2658927621","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658927621?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 16:08","pubTimestamp":1786522123,"startTime":"0","endTime":"0","summary":"美国研究综述-卡迪纳尔健康、卢门图姆控股、公共仓储路透8月12日-周三，华尔街证券分析师调整了多家在美国上市公司的评级和目标股价，其中包括卡迪纳尔健康、卢门图姆控股和公共仓储。股票按字母顺序排列。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL4S4490GS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXR","MAA","HD","LOW","ACVA","JAZZ","REIT","GAP","CANC","URBN","PNW","LBRX","ANF","CRCL","CAH","BLCK","RPD","USFD","FLUT","BBIO","CRWV","PSA","NEMG","LPTH","UMAC","AMBQ","LEGN","NTRA","COAG","CVS","BCAX","EGGY","TGT","MRCY","MDLN","WELL","MNST","TXG","JBIO","CAVA","NEM","LENZ","ACM","MIDD","SGMT","CUBE","LITE","SR","VTR","HLIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183732399","title":"H.C. Wainwright 首次覆蓋 Hemab Therapeutics，給予「買入」評級及40美元目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=1183732399","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183732399?lang=zh_tw&edition=fundamental","pubTime":"2026-06-17 18:08","pubTimestamp":1781690902,"startTime":"0","endTime":"0","summary":"投资机构 H.C. Wainwright 近日启动了对 Hemab Therapeutics Holdings, Inc. 的研究覆盖，并给予了“买入”评级。该机构为这家生物技术公司设定了每股40美元的目标价格。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638473599","title":"美國研究綜述-阿波羅、菲利普斯66、瓦萊羅能源","url":"https://stock-news.laohu8.com/highlight/detail?id=2638473599","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638473599?lang=zh_tw&edition=fundamental","pubTime":"2026-05-26 15:32","pubTimestamp":1779780727,"startTime":"0","endTime":"0","summary":"美国研究综述-阿波罗、菲利普斯66、瓦莱罗能源路透5月26日 - 周二，华尔街证券分析师调整了多家在美国上市公司的评级和目标股价，其中包括阿波罗、菲利普斯66和瓦莱罗能源。股票条目按字母顺序排列。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nL4T4230EH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COAG","IE00B19Z3581.USD","LU0096364046.USD","LU0300736062.USD","LU1861214812.USD","LU0266512473.USD","BK4138","LU2095319765.USD","TKR","TDS","BK4548","SPTX","LU1201861249.SGD","BK4585","LU0205194284.USD","LU0274383776.USD","IE00B775SV38.USD","BAH","LU0477156953.USD","ALB","APO","BK4161","LU1803068623.USD","HLIO","ALBG","BK4139","AD","LU0266512127.USD","PSX","LU0630314457.HKD","LU0456854461.SGD","IE00BZ1G4Q59.USD","MPC","ALNT","LU0345780950.USD","RRX","BK4157","BK4155","LU0170899867.USD","TTAN","BJ","LU0130517989.USD","PS","LU0980610538.SGD","LU1206713676.USD","VLO","LU2106854487.HKD","LU0266013472.USD","CGNX","LU1169589451.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630437375","title":"諾和諾德基金會參投的生物科技公司Hemab(COAG.US)擬赴美IPO，最高募資2.12億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630437375","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630437375?lang=zh_tw&edition=fundamental","pubTime":"2026-04-28 16:00","pubTimestamp":1777363239,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，临床阶段生物科技公司Hemab Therapeutics Holdings Inc.正寻求在美国首次公开募股中最高融资2.12亿美元。此次生物科技公司IPO的背景是，投资者对减肥药物开发商Kailera Therapeutics Inc.给予了热烈反响——该公司于本月初上市，募资7.19亿美元，创下2021年以来该行业在美国最大的IPO记录。招股文件还显示，在本次发行前，RA Capital Management的关联实体与诺和诺德基金会分别持有Hemab 18%和15%的股份。截至2025年12月31日，公司持有现金及现金等价物共1.85亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435195.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4581","BK4585","NVOH","COAG","BK4588","BK4532","BK4007","LU1093756325.SGD","IE00BZ1G4Q59.USD","LU1093756168.USD","LU0154236417.USD","NVOX","BK4599","NVO","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195572245","title":"Hemab Therapeutics Holdings Inc提交SEC文件：預計IPO股價區間為16-18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1195572245","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195572245?lang=zh_tw&edition=fundamental","pubTime":"2026-04-27 19:22","pubTimestamp":1777288965,"startTime":"0","endTime":"0","summary":"根据最新提交给美国证券交易委员会（SEC）的文件显示，生物制药公司Hemab Therapeutics Holdings Inc首次公开募股（IPO）的初步定价区间已确定为每股16美元至18美元。\n这一价格区间标志着该公司正式迈出登陆公开资本市场的关键一步。若按此区间上限计算，此次IPO有望为Hemab Therapeutics募集可观的资金，用于推进其创新疗法的研发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COAG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}]}}